GlassScriptPhysician profile
Steven A Walters
NPI 1700808110
$3,264.77
in general payments reported to CMS, 2019-2025
26 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $40.04 · 2021: $98.65 · 2022: $196 · 2023: $779 · 2024: $633 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175 · Education: $58.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.08 |
| Education | $58.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,231.15 | 2019-2025 | Citrefix, Ortholoc 2 Lapifuse, Augment Injectable |
| Abbott Laboratories | $294.65 | 2022-2025 | Proclaim, Eterna |
| Core Surgical Group | $261.25 | 2023-2025 | |
| Nevro Corp. | $254.50 | 2023-2024 | Senza |
| Wright Medical Technology, INC. | $178.51 | 2019-2020 | |
| Medtronic, INC. | $174.41 | 2024 | Intellis Adaptivestim |
| Bioventus LLC | $164.57 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Medinc of Texas | $130.78 | 2022 | |
| Cook Medical LLC | $105.76 | 2019 | |
| Orthofix Medical, INC. | $58.19 | 2020-2025 | Physio-Stim |
| Paragon 28, INC. | $51.41 | 2024-2025 | Bun-Yo-Matic, Grappler |
| Integra Lifesciences Corporation | $47.23 | 2021 | |
| Globus Medical, INC. | $35.70 | 2025 | Senza, Nevro |
| Sebela Pharmaceuticals INC. | $28.80 | 2019 | |
| Boston Scientific Corporation | $27.12 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $26.81 | 2019 | |
| Axogen | $23.33 | 2019 | |
| Alfasigma USA, INC. | $22.89 | 2022 | |
| Depuy Synthes Sales INC. | $22.25 | 2024 | |
| Smith+Nephew, INC. | $21.21 | 2021 | |
| Treace Medical Concepts, INC. | $20.78 | 2023 | |
| Amgen INC. | $20.70 | 2024 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $16.33 | 2025 | |
| Heron Therapeutics, INC. | $16.27 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.06 | 2019 | |
| Acera Surgical, INC. | $14.11 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.